title: TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION.
authors.forename: Ann Marie
authors.initials: AM
authors.lastname: Effingham
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000600:supply & distribution; D044966:Anti-Retroviral Agents / Q000191:economics / Q000600:supply & distribution; D000970:Antineoplastic Agents / Q000600:supply & distribution; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003132:Commerce / Q000331:legislation & jurisprudence*; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution; D033161:Government Regulation; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D018973:Intellectual Property; D007880:Legislation, Drug; D008004:Licensure / Q000331:legislation & jurisprudence; D037141:Mandatory Programs / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*; D012107:Research Design / Q000331:legislation & jurisprudence*; D013785:Thailand; D014481:United States; D014486:United States Food and Drug Administration; D014944:World Health Organization
chemical_list: D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D000970:Antineoplastic Agents; D016568:Drugs, Generic; D004364:Pharmaceutical Preparations